cushieblog.com
Long-acting pasireotide provides ‘sustained biochemical improvements’ in Cushing’s disease
For patients with persistent or recurring Cushing’s disease, monthly pasireotide therapy was safe and effective, leading to normal urinary free cortisol levels in 47% of patients after 2 years, acc…